Research and analysis

ISARIC4C and CO-CIN: Co-infection with influenza viruses associated with worse outcomes in severe COVID-19, 7 February 2022

Clinical information provided to the Scientific Advisory Group for Emergencies (SAGE) and the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG).

• From: Scientific Advisory Group for Emergencies
• Published: 18 February 2022

Documents

ISARIC4C and CO-CIN: Co-infection with influenza viruses associated with worse outcomes in severe COVID-19, 7 February 2022

PDF, 939 KB, 29 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email contact@go-science.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Update paper prepared by the ISARIC4C (Coronavirus Clinical Characterisation Consortium) and COVID-19 Clinical Information Network (CO-CIN) for SAGE and NERVTAG. This paper was available for participants to read at SAGE 105 on 10 February 2022, but not considered or discussed in the meeting. As new evidence or data emerges, SAGE updates its advice accordingly.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Published 18 February 2022